Hosted on MSN6d
Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses ExpectationsBiopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced in Q4 CY2024, with sales up 7.5% year on year to $12.34 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback